BioSig Technologies (OTCQB: BSGM) issued a letter to its shareholders today, updating them on the company’s recent developments and revealing that it tapped Minnetronix to develop the 1st version of its Pure EP system.
The Minneapolis-based company is developing a cardiac signal acquisition and display system which is designed to assist electrophysiologists in making clinical decisions for patients with abnormal heart rates and rhythms, including atrial fibrillation and ventricular tachycardia.
Get the full story at our sister site, Medical Design & Outsourcing.
The post BioSig taps Minnetronix to develop Pure EP prototype appeared first on MassDevice.
from MassDevice http://ift.tt/2jW7Zxh
Cap comentari:
Publica un comentari a l'entrada